William Pao
Vanderbilt University(US)Weatherford College(US)Cancer Research Center(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, HER2/EGFR in Cancer Research, Colorectal Cancer Treatments and Studies, Cancer therapeutics and mechanisms
Most-Cited Works
- → EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib(2004)4,332 cited
- → Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain(2005)3,519 cited
- → Somatic mutations affect key pathways in lung adenocarcinoma(2008)2,732 cited
- → Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR -Mutant Lung Cancers(2013)2,447 cited
- → AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer(2014)2,182 cited
- → Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing(2012)1,820 cited